With their lengthening laundry list of health benefits, drugs like Ozempic and Wegovy are showing promise outside of weight loss and diabetes treatments. One of the most exciting off-label uses of these so-called GLP-1 drugs, which mimic the stomach's feeling of fullness and appear to curb cravings, is in addiction treatment — and as STAT News reports, one posh Pennsylvania rehabilitation center is giving it to patients for exactly that purpose. The all-inclusive Caron Treatment Center, a nonprofit rehab facility located about 70 miles from Philadelphia, has begun prescribing low doses of semaglutide, the active ingredient in Novo Nordisk's Ozempic and […]